CLINICAL_TRIALS
trial_result
· 2021-08-24
Clinical Trial Update: Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients [Phase 3]
Summary
Phase 3 clinical trial evaluating Gallium-68 PSMA-11 PET imaging in prostate cancer completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Thomas Hope | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-08-24